Scientific Program

as of January 2026


08:30 AM – 09:15 AM	Breakfast
09:15 AM – 09:45 AM	Effects of obesity on the immune system – How do GLP1’s intervene? Lydia Lynch, Princeton, NJ
09:45 AM – 10:15 AM	Potential role of GLP1 in reducing inflammation in rheumatological diseases Alexis R. Ogdie, Philadelphia, PA
10:15 AM – 10:45 AM	Dermatology–GI cross indications and potential of GLP1 as an add on therapy Ahuva Cices, New York, NY
10:45 AM – 11:15 AM	Hidradenitis suppurativa, obesity and GLP1s James G. Krueger, New York, NY
11:15 AM – 11:45 AM	Skin inflammaging Helen He, New York, NY
11:45 AM – 12:45 PM	Lunch
12:45 PM – 01:15 PM	Effect of GLP1s on the skin and potential treatments Doris Day, New York, NY
01:15 PM – 01:45 PM	Psoriasis and the Cardiometabolic Syndrome Mark Lebwohl, New York, NY
01:45 PM – 02:15 PM	GLP1’s and MASH Meena Bansal, New York, NY
02:15 PM – 02:45 PM	Effects of GLP-1’s on the gut Marla Dubinsky, New York, NY
02:45 PM – 03:15 PM	Break
03:15 PM – 03:45 PM	The mental health impact of GLP1s Rachel Goldman, New York, NY
03:45 PM – 04:15 PM	How GLP1s fit in treating the cardiometabolic syndrome Deepak L. Bhatt, New York, NY
04:15 PM – 04:45 PM	GLP1: The past, present and future Mark Genovese, Indianapolis, IN
05:00 PM	Adjournment